Inventor · disambiguated record
David S. Alberts
Also filed as: ALBERTS DAVID S
14 granted patents·13 pending applications·363 citations·filing 1985–2012
94Inventor score
Files withALBERTS DAVID S3TOPICAL TECHNOLOGIES INC3UNIV ARIZONA3CANCER TECHNOLOGIES INC2MEDIMMUNE LLC2
Top patents by PatentIndex Score
27 records- 0187US5994409AMethods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compoundsUS BIOSCIENCE·Filed 1997·Granted Nov 30, 1999·53 cites·40 claims
- 0280US9320764B2Method for producing Vitamin D in a personALBERTS DAVID S·Filed 2011·Granted Apr 26, 2016·2 cites·11 claims
- 0380US5635506A1, 2-dihydro-3H-dibenzisoquinoline-1,3-dione anticancer agentsRES CORP TECHNOLOGIES INC·Filed 1993·Granted Jun 3, 1997·26 cites·83 claims
- 0476US5246955AAntineoplastic compounds and methods of using sameRES CORP TECHNOLOGIES INC·Filed 1992·Granted Sep 21, 1993·17 cites·9 claims
- 0571US6060083ATopical DMSO treatment for palmar-plantar erythrodysethesiaTOPICAL TECHNOLOGIES INC·Filed 1999·Granted May 9, 2000·32 cites·6 claims
- 0670US2008146653A1Synergistic anti-cancer compositionsUNIV ARIZONA·Filed 2007·Application pending·0 cites
- 0770US2008153891A1Synergistic anti-cancer compositionsUNIV ARIZONA·Filed 2007·Application pending·0 cites
- 0867US4906236ASelf-sheathing hypodermic needleALBERTS DAVID S·Filed 1988·Granted Mar 6, 1990·107 cites·9 claims
- 0967US2010226946A1Apparatus and Method for Producing Vitamin D in a PersonTOPICAL TECHNOLOGIES INC·Filed 2009·Application pending·0 cites
- 1066US2005176696A1Synergistic anit-cancer compoundsUNIV ARIZONA·Filed 2004·Application pending·0 cites
- 1165US7105575B2Methods for the treatment of neuro- disorders using aminothiol compoundsMEDIMMUNE ONCOLOGY INC·Filed 2002·Granted Sep 12, 2006·1 cites·6 claims
- 1265US6586476B1Methods for the treatment of nephro-disorders using aminothiol compoundsMEDIMMUNE ONCOLOGY INC·Filed 1999·Granted Jul 1, 2003·13 cites·19 claims
- 1362US2004106588A1Topical application of alpha-DFMO and steroid to treat Vulvar Intraepithelial NeoplasiaFiled 2003·Application pending·0 cites
- 1460US6204064B1Measurement of lesion progression via mapping of chromatin texture features along progression curveFiled 1999·Granted Mar 20, 2001·24 cites·24 claims
- 1560US5851537ATopical application of α-DFMO for preventing skin cancerCANCER TECHNOLOGIES INC·Filed 1997·Granted Dec 22, 1998·21 cites·5 claims
- 1660US2013090312A1Methods of use related to xerostomiaMEDIMMUNE LLC·Filed 2012·Application pending·0 cites
- 1760US2006270636A1Methods for treatment of neuro- and nephro- disorders and therapeutic toxicities using aminothiol compoundsARIZONA UNIVERSITY·Filed 2006·Application pending·0 cites
- 1859US2004043975A1Topical application of alpha-DFMO and topical steroid for treatment of actinic keratosesTOPICAL TECHNOLOGIES INC·Filed 2003·Application pending·0 cites
- 1957US2003129208A1Topical application of alpha-DFMO and anti-inflammatory drug for treatment of actinic keratosesFiled 2002·Application pending·0 cites
- 2056US2011166108A1Methods of use related to xerostomiaMEDIMMUNE LLC·Filed 2010·Application pending·0 cites
- 2156US2007213354A1Compositions and Methods for the Treatment of Multiple SclerosisAMPLIMED CORP·Filed 2007·Application pending·0 cites
- 2254US2006040903A1Methods of use related to xerostomiaSTOGNIEW MARTIN·Filed 2005·Application pending·0 cites
- 2351US5811113AMethod and composition for deactivating HIV infected blood and for deactivating and decolorizing anticancer drugsCANCER TECHNOLOGIES INC·Filed 1992·Granted Sep 22, 1998·29 cites·4 claims
- 2451USD310044SInstrument for measuring tumorsALBERTS DAVID S·Filed 1987·Granted Aug 21, 1990·6 cites·1 claims
- 2551US2005142078A1Method of stimulation of melanin production and induction of skin tanningFiled 2003·Application pending·0 cites
- 2647US4657032AAspiration device for a smoking articleDORR ROBERT T·Filed 1985·Granted Apr 14, 1987·14 cites·8 claims
- 2745US5985302AMethod for deactivating a contaminantSUPERGEN INC·Filed 1998·Granted Nov 16, 1999·18 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →